Gemmily 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Provider Briefing: Gemmily 28 Day Availability in 2026

If your patients have been calling about difficulty filling their Gemmily 28 Day prescriptions, this briefing provides the clinical and logistical context you need. Since late 2025, intermittent supply disruptions have made this combination oral contraceptive difficult to find at many retail pharmacies — particularly major chains.

This article covers the shortage timeline, prescribing implications, therapeutic alternatives, cost and access considerations, and tools to support your practice and your patients.

Product Overview

Gemmily (norethindrone acetate 1 mg / ethinyl estradiol 20 mcg capsules and ferrous fumarate capsules) is a 28-day combination oral contraceptive manufactured by Xiromed, LLC. It is the AB-rated generic equivalent of Taytulla (Allergan/AbbVie), approved by the FDA in November 2020.

Key distinguishing feature: Gemmily is formulated as soft gelatin capsules rather than conventional tablets. The 24/4 regimen includes 24 active hormone capsules followed by 4 ferrous fumarate placebo capsules.

Shortage Timeline

• November 2025: Initial patient reports of Gemmily backorders at chain pharmacies (CVS, Walgreens, Rite Aid). Patient forum discussions indicate widespread difficulty locating the medication.
• December 2025 – January 2026: Reports continued across multiple regions. Some patients reported calling 5 to 10+ pharmacies before finding stock. Independent pharmacies appeared less affected.
• February – March 2026: Availability has gradually improved in some markets, but remains inconsistent. Gemmily is not listed on the FDA Drug Shortage Database or ASHP shortage list as of March 2026.

The absence from official shortage databases suggests this may be classified as a distribution or allocation issue rather than a formal manufacturing shortage. However, the practical impact on patients has been significant.

Prescribing Implications

Contraceptive Continuity

Gaps in oral contraceptive access pose a direct risk of unintended pregnancy. When patients cannot fill their Gemmily prescription, it is critical to provide a timely therapeutic alternative to maintain continuous coverage. Even short gaps — missing 7+ days of active pills — can result in loss of contraceptive efficacy and require backup methods.

Dosage Form Considerations

Gemmily's soft gelatin capsule formulation is not directly interchangeable at the pharmacy level with tablet-form products containing the same active ingredients. A new prescription is required to switch patients to a tablet-form equivalent such as Junel Fe 1/20 or Microgestin Fe 1/20. Pharmacists cannot make this substitution without prescriber authorization.

Switching Guidance

When switching from Gemmily to a tablet-form COC with the same hormonal composition:

• Instruct the patient to start the new product on the day after the last active Gemmily capsule or, if on placebo capsules, on the day the next active capsule would have been taken.
• No backup contraception is needed if the switch is seamless (no hormone-free days beyond the standard 4-day placebo window).
• If there is any gap in active hormone coverage, advise backup contraception for 7 consecutive days on the new product.

Current Availability Picture

Based on pharmacy distribution data and patient reports:

• Chain pharmacies: Inconsistent availability. Automated inventory systems may not restock Gemmily at locations with lower historical demand.
• Independent pharmacies: Generally better success sourcing Gemmily through alternate wholesaler channels.
• Mail-order pharmacies: Variable — some mail-order programs may have stock while retail locations do not.

Providers can direct patients to Medfinder for Providers to check real-time pharmacy availability in their area.

Cost and Access Considerations

Pricing

• Gemmily retail cash price: $181 – $225 per 28-day pack
• With discount coupons (GoodRx/SingleCare): $24 – $27 per pack
• Taytulla (brand) retail price: $200 – $300+ per pack
• Taytulla with Allergan savings card: As low as $25/fill for commercially insured patients
• Tablet-form generics (Junel Fe 1/20, Microgestin Fe 1/20): $10 – $35 with coupons; often $0 with ACA-compliant insurance

Insurance Coverage

Under the ACA contraceptive mandate, most commercial insurance plans must cover at least one formulation of each FDA-approved contraceptive method at $0 cost-sharing. However, plans may tier specific products differently. If Gemmily is not on formulary, the plan must cover a therapeutic alternative without cost to the patient.

Tools and Resources for Your Practice

• Medfinder for Providers: Real-time pharmacy availability search — helps your team direct patients to pharmacies with stock.
• Allergan Savings Card (Taytulla): allergansavingscard.com/taytulla — may help bridge gaps if patients can access brand Taytulla.
• NeedyMeds / RxAssist: Patient assistance program databases for uninsured or underinsured patients.
• Discount coupon platforms: GoodRx, SingleCare, and BuzzRx all offer significant discounts on Gemmily for cash-pay patients.

For a comprehensive guide on helping patients manage costs, see: How to Help Patients Save Money on Gemmily 28 Day: A Provider's Guide.

Looking Ahead

Several factors could improve Gemmily availability in the coming months:

• Xiromed production increases: As the sole manufacturer, any capacity expansion would directly improve supply.
• Additional generic entrants: If other manufacturers pursue ANDA approvals for the soft gelatin capsule formulation, the supply base would broaden.
• Distribution optimization: Better demand forecasting by wholesalers and chain pharmacies could reduce spot shortages.

In the interim, proactive prescribing — including standing alternative prescriptions for patients on Gemmily — can help ensure contraceptive continuity.

Final Thoughts

The Gemmily 28 Day supply situation requires provider awareness and proactive planning. While the shortage is not formally listed, it is affecting real patients who depend on this medication for pregnancy prevention. By understanding the availability landscape, having switching protocols ready, and directing patients to resources like Medfinder for Providers, you can help ensure your patients maintain uninterrupted contraceptive coverage.

Related provider resources:

• How to Help Your Patients Find Gemmily 28 Day in Stock: A Provider's Guide
• How to Help Patients Save Money on Gemmily 28 Day
• Alternatives to Gemmily 28 Day